BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 38655786)

  • 1. The performance of marginal structural models for estimating risk differences and relative risks using weighted univariate generalized linear models.
    Austin PC
    Stat Methods Med Res; 2024 Jun; 33(6):1055-1068. PubMed ID: 38655786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bootstrap vs asymptotic variance estimation when using propensity score weighting with continuous and binary outcomes.
    Austin PC
    Stat Med; 2022 Sep; 41(22):4426-4443. PubMed ID: 35841200
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Variance estimation when using inverse probability of treatment weighting (IPTW) with survival analysis.
    Austin PC
    Stat Med; 2016 Dec; 35(30):5642-5655. PubMed ID: 27549016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Variance estimation of the risk difference when using propensity-score matching and weighting with time-to-event outcomes.
    Cafri G; Austin PC
    Pharm Stat; 2023; 22(5):880-902. PubMed ID: 37258420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variance estimators for weighted and stratified linear dose-response function estimators using generalized propensity score.
    Garès V; Chauvet G; Hajage D
    Biom J; 2022 Jan; 64(1):33-56. PubMed ID: 34327720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. On variance estimation of the inverse probability-of-treatment weighting estimator: A tutorial for different types of propensity score weights.
    Kostouraki A; Hajage D; Rachet B; Williamson EJ; Chauvet G; Belot A; Leyrat C
    Stat Med; 2024 Jun; 43(13):2672-2694. PubMed ID: 38622063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The performance of different propensity-score methods for estimating differences in proportions (risk differences or absolute risk reductions) in observational studies.
    Austin PC
    Stat Med; 2010 Sep; 29(20):2137-48. PubMed ID: 20108233
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in target estimands between different propensity score-based weights.
    Austin PC
    Pharmacoepidemiol Drug Saf; 2023 Oct; 32(10):1103-1112. PubMed ID: 37208837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The performance of inverse probability of treatment weighting and full matching on the propensity score in the presence of model misspecification when estimating the effect of treatment on survival outcomes.
    Austin PC; Stuart EA
    Stat Methods Med Res; 2017 Aug; 26(4):1654-1670. PubMed ID: 25934643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A generalized-weights solution to sample overlap in meta-analysis.
    Bom PRD; Rachinger H
    Res Synth Methods; 2020 Nov; 11(6):812-832. PubMed ID: 32790019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving causal inference with a doubly robust estimator that combines propensity score stratification and weighting.
    Linden A
    J Eval Clin Pract; 2017 Aug; 23(4):697-702. PubMed ID: 28116816
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity score weighting analysis and treatment effect discovery.
    Mao H; Li L; Greene T
    Stat Methods Med Res; 2019 Aug; 28(8):2439-2454. PubMed ID: 29921162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variance estimation in inverse probability weighted Cox models.
    Shu D; Young JG; Toh S; Wang R
    Biometrics; 2021 Sep; 77(3):1101-1117. PubMed ID: 32662087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On Variance of the Treatment Effect in the Treated When Estimated by Inverse Probability Weighting.
    Reifeis SA; Hudgens MG
    Am J Epidemiol; 2022 May; 191(6):1092-1097. PubMed ID: 35106534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The use of bootstrapping when using propensity-score matching without replacement: a simulation study.
    Austin PC; Small DS
    Stat Med; 2014 Oct; 33(24):4306-19. PubMed ID: 25087884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Informing power and sample size calculations when using inverse probability of treatment weighting using the propensity score.
    Austin PC
    Stat Med; 2021 Nov; 40(27):6150-6163. PubMed ID: 34510501
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing the performance of the generalized propensity score for estimating the effect of quantitative or continuous exposures on binary outcomes.
    Austin PC
    Stat Med; 2018 May; 37(11):1874-1894. PubMed ID: 29508424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Closed-form variance estimator for weighted propensity score estimators with survival outcome.
    Hajage D; Chauvet G; Belin L; Lafourcade A; Tubach F; De Rycke Y
    Biom J; 2018 Nov; 60(6):1151-1163. PubMed ID: 30257058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The performance of different propensity score methods for estimating marginal hazard ratios.
    Austin PC
    Stat Med; 2013 Jul; 32(16):2837-49. PubMed ID: 23239115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Addressing Extreme Propensity Scores via the Overlap Weights.
    Li F; Thomas LE; Li F
    Am J Epidemiol; 2019 Jan; 188(1):250-257. PubMed ID: 30189042
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.